Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate

This publication has 12 references indexed in Scilit:

• Home cage behavior and lead treatment in rhesus monkeys: A comparison with open-field behavior
  Neurotoxicology and Teratology, 1993
• Lasting Neuropsychiatric Sequelae of (??)Methylenedioxymethamphetamine (???Ecstasy???) in Recreational Users
  Journal of Clinical Psychopharmacology, 1991
• Effects of postnatal lead exposure on open field behavior in monkeys
  Neurotoxicology and Teratology, 1990
• 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
  The Journal of Pharmacology and Experimental Therapeutics, 1989
• (±3,4-Methylenedioxymethamphetamine Selectively Damages Central Serotonergic Neurons in Nonhuman Primates
  JAMA, 1988
• Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA)
  Toxicology and Applied Pharmacology, 1988
• Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration
  Brain Research, 1988
• Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat
  Fundamental and Applied Toxicology, 1987
• Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
  The Journal of Pharmacology and Experimental Therapeutics, 1987
• Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates
  Brain Research, 1979